Evidence map›Paper›PMID 20513749›Full record

ArticleThe Journal of experimental medicine2010

Innate immunity defines the capacity of antiviral T cells to limit persistent infection.

Daniel M Andrews, Marie J Estcourt, Christopher E Andoniou, Matthew E Wikstrom, Andrea Khong, Valentina Voigt, Peter Fleming, Hyacinth Tabarias, Geoffrey R Hill, Robbert G van der Most and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 203 citations in OpenAlex.

  1. Unconventional functions of natural killer cells in homeostasis and disease.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Daniel M AndrewsImmunology and Virology Program, Centre for Ophthalmology and Visual Science, University Department of Medicine, University of Western Australia, Nedlands, Western Australia 6009, Australia.
Marie J Estcourt
Christopher E Andoniou
Matthew E Wikstrom
Andrea Khong
Valentina Voigt
Peter Fleming
Hyacinth Tabarias
Geoffrey R Hill
Robbert G van der Most
Anthony A Scalzo
Mark J Smyth
Mariapia A Degli-Esposti
University of Western Australia · AULions Eye Institute · AUPeter MacCallum Cancer Centre · AUQIMR Berghofer Medical Research Institute · AU

Funding

Wellcome Trust
6 · The paper itself

Abstract

Effective immunity requires the coordinated activation of innate and adaptive immune responses. Natural killer (NK) cells are central innate immune effectors, but can also affect the generation of acquired immune responses to viruses and malignancies. How NK cells influence the efficacy of adaptive immunity, however, is poorly understood. Here, we show that NK cells negatively regulate the duration and effectiveness of virus-specific CD4+ and CD8+ T cell responses by limiting exposure of T cells to infected antigen-presenting cells. This impacts the quality of T cell responses and the ability to limit viral persistence. Our studies provide unexpected insights into novel interplays between innate and adaptive immune effectors, and define the critical requirements for efficient control of viral persistence.

Indexed as

AnimalsAntiviral AgentsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCytotoxicity, ImmunologicDendritic CellsEpitopesHistocompatibility AntigensImmunity, InnateKiller Cells, NaturalLymphocyte ActivationMiceMice, Inbred BALB CNK Cell Lectin-Like Receptor Subfamily APeptidesVirus DiseasesAntiviral AgentsEpitopesHistocompatibility AntigensNK Cell Lectin-Like Receptor Subfamily APeptides

Identifiers

PMID20513749
PMCPMC2882831
OpenAlexW2134438797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.